Answers are grounded in this paper and cite their sources.
Data on the epidemiology and pathogenesis of alcoholic cardiomyopathy (ACMP) are presented. Special aspects of clinical manifestations as well as management of these patients are considered. Psychotropic therapy aimed at reduction in motivation to alcohol consumption in patients with ACMP is discussed separately.
No takes yet. Share an insight, caveat, or question.
A. O. Yusupova (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: